Literature DB >> 14638820

High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent.

Andrea Debus1, Joachim Gläsner, Martin Röllinghoff, André Gessner.   

Abstract

Myeloid differentiation protein 88 (MyD88) is a general adaptor for the signaling cascade through receptors of the Toll/IL-1R family. When infected with Leishmania major parasites, MyD88-deficient mice displayed a dramatically enhanced parasite burden in their tissues similar to that found in susceptible BALB/c mice. In contrast, MyD88 knockout mice did not develop ulcerating lesions despite a lack of interleukin-12 (IL-12) production and a predominant T helper 2 cell response. Blockade of IL-4 produced early (day 1) after infection restored a protective T helper 1 response in MyD88 knockout mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638820      PMCID: PMC308890          DOI: 10.1128/IAI.71.12.7215-7218.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Toll-like receptors and their ligands.

Authors:  G M Barton; R Medzhitov
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 2.  MyD88 as a bottle neck in Toll/IL-1 signaling.

Authors:  O Takeuchi; S Akira
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 3.  Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation.

Authors:  Jacques Louis; Alain Gumy; Heike Voigt; Martin Röcken; Pascal Launois
Journal:  Eur J Dermatol       Date:  2002 Jul-Aug       Impact factor: 3.328

4.  MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.

Authors:  Brian T Edelson; Emil R Unanue
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

5.  Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis.

Authors:  A Gessner; K Schröppel; A Will; K H Enssle; L Lauffer; M Röllinghoff
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

Authors:  Charles A Scanga; Julio Aliberti; Dragana Jankovic; Florence Tilloy; Soumaya Bennouna; Eric Y Denkers; Ruslan Medzhitov; Alan Sher
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway.

Authors:  Thomas R Hawn; Adrian Ozinsky; David M Underhill; Frederick S Buckner; Shizuo Akira; Alan Aderem
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

8.  IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.

Authors:  T Scharton-Kersten; L C Afonso; M Wysocka; G Trinchieri; P Scott
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

9.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

Authors:  S Stenger; H Thüring; M Röllinghoff; C Bogdan
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  26 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Authors:  Abdul Q Khan; Quanyi Chen; Zheng-Qi Wu; James C Paton; Clifford M Snapper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

4.  MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.

Authors:  K A Rogers; A B Rogers; B A Leav; A Sanchez; E Vannier; S Uematsu; S Akira; D Golenbock; H D Ward
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 5.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

6.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

7.  UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major.

Authors:  Bruno Luiz Fonseca Schamber-Reis; Patricia M Petritus; Braulia C Caetano; Espiridion R Martinez; Kendi Okuda; Douglas Golenbock; Phillip Scott; Ricardo T Gazzinelli
Journal:  J Biol Chem       Date:  2013-01-16       Impact factor: 5.157

8.  Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major.

Authors:  Simone Antoniazi; Helen P Price; Pascale Kropf; Marina A Freudenberg; Chris Galanos; Deborah F Smith; Ingrid Müller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.

Authors:  Onyinye I Iweala; Donald W Smith; Kabir S Matharu; Isabel Sada-Ovalle; Deanna D Nguyen; Rosemarie H Dekruyff; Dale T Umetsu; Samuel M Behar; Cathryn R Nagler
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

Review 10.  Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation.

Authors:  Tracy Raymond; Matthew Schaller; Cory M Hogaboam; Nicholas W Lukacs; Rosemary Rochford; Steven L Kunkel
Journal:  Proc Am Thorac Soc       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.